| Financial Year |
March 31 2023 |
| Monetary Funds |
78,937,728.42 |
| Held-for-trading Financial Assets |
96,067,386.69 |
| Notes Receivable |
-- |
| Accounts Receivable |
7,556,878.13 |
| Advances to Suppliers |
2,280,916.87 |
| Other Receivables |
3,004,440.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
108,308,386.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,154,273.02 |
| Total Current Assets |
299,310,010.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,838,484.09 |
| Fixed Assetes |
135,822,672.79 |
| Under-construction Projects |
5,545,646.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,897,369.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,239,622.51 |
| Deferred Income Tax Assets |
4,838,958.58 |
| Other Non-Current Assets |
99,471.60 |
| Sub-Total of Non-Current Assets |
155,282,225.39 |
| Total Assets |
454,592,236.14 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
29,037,986.00 |
| Accounts Received In Advance |
3,189,671.98 |
| Employee Compensation Payable |
5,927,351.79 |
| Taxes Payable |
2,227,990.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,698,973.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,168,646.43 |
| Sub-Total of Current Liabilities |
53,250,620.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
603,126.40 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,975,379.85 |
| Total Liabilities |
57,226,000.38 |
| Paid-In Capital(Or Share Stock) |
149,611,680.00 |
| Capital Surplus |
114,158,780.44 |
| Surplus Reserve |
23,589,876.83 |
| LESS:Treasury Stock |
30,000,557.33 |
| Undistributed Profits |
140,146,764.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
397,366,235.76 |
| Owner's Equity（Stockholder's Equity） |
397,366,235.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
454,592,236.14 |
